Fig. 2
After 6 months, change in BMI SDS, IGF-1, CRP, lgALT, AST, lgGGT, lgHDL-C and LDL-C in rhGH treatment group compared with untreated control group. * p < 0.05 vs control group
Fig. 2 | BMC Endocrine Disorders
After 6 months, change in BMI SDS, IGF-1, CRP, lgALT, AST, lgGGT, lgHDL-C and LDL-C in rhGH treatment group compared with untreated control group. * p < 0.05 vs control group